Correction: Tissue biodistribution and tumor targeting of near-infrared labelled anti-CD38 antibody-drug conjugate in preclinical multiple myeloma
Nicholas Cho, Sooah Ko, Monica Shokeen
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsMultiple Myeloma Research and Treatments · Cancer Treatment and Pharmacology · Peptidase Inhibition and Analysis
This article has been corrected: Oncotarget’s investigation of the paper is now complete. We’ve determined that in Figure 3A, the Day 0 representative image of MM.1S SQ mice in the “DARA-IR” group was unintentionally duplicated from the Day 2 image, taken before the fluorescent imaging. This error happened during the figure assembly process. The authors have removed the Day 0 images for both groups of mice. As stated in the Figure 3A caption, the figure is intended to show mice at days 2 and 9 post-dye administration. The authors declare that these modifications to the figures do not change the results or conclusions of the paper.
Original article: Oncotarget. 2021; 12:2039–2050. 2039-2050. https://doi.org/10.18632/oncotarget.28074